{"product_id":"tylosin-tartrate-cas-74610-55-2","title":"Tylosin Tartrate (CAS 74610-55-2) | Antibiotic Powder for Laboratory \u0026 Research Use","description":"\u003c!--\n  AuSaMicS Life Science™ | Tylosin Tartrate | ASA-2056\n  CSS-only tabs — no JavaScript — Shopify safe\n--\u003e\n\u003cdiv id=\"au-tyl2056\"\u003e\n\u003cstyle\u003e\n#au-tyl2056{\n  --g1:#1A4731;--g2:#2D6A4F;--ga:#EAF4EE;--gb:#F5FAF7;\n  --bk:#111827;--ch:#374151;--gx:#6B7280;--lt:#E5E7EB;--wh:#FFFFFF;\n  --or:#B45309;--bl:#1E40AF;--rd:#991B1B;\n  font-family:'Segoe UI',system-ui,sans-serif;font-size:14px;color:var(--bk);\n  max-width:980px;margin:0 auto;background:var(--wh);\n  border:1px solid var(--lt);border-radius:4px;overflow:hidden;\n}\n#au-tyl2056 .r{position:absolute;opacity:0;pointer-events:none;width:0;height:0}\n#au-tyl2056 .hdr{background:var(--g1);padding:26px 32px 22px;display:flex;align-items:flex-start;justify-content:space-between;gap:24px}\n#au-tyl2056 .hdr-l{flex:1}\n#au-tyl2056 .cat{font-size:10px;font-weight:700;letter-spacing:.12em;color:#7EC8A0;text-transform:uppercase;margin-bottom:6px}\n#au-tyl2056 .pname{font-size:22px;font-weight:800;color:var(--wh);line-height:1.2;margin-bottom:3px}\n#au-tyl2056 .psub{font-size:12px;color:#9FD4B4;font-style:italic;margin-bottom:14px}\n#au-tyl2056 .badges{display:flex;flex-wrap:wrap;gap:6px}\n#au-tyl2056 .badge{font-size:10px;font-weight:600;padding:3px 10px;border:1px solid rgba(255,255,255,.22);border-radius:2px;color:rgba(255,255,255,.82);background:rgba(255,255,255,.07)}\n#au-tyl2056 .hdr-r{text-align:right;flex-shrink:0}\n#au-tyl2056 .brand{font-size:13px;font-weight:700;color:var(--wh);letter-spacing:.04em}\n#au-tyl2056 .brand-s{font-size:9px;color:#7EC8A0;letter-spacing:.1em;text-transform:uppercase;margin-top:2px}\n#au-tyl2056 .strip{display:grid;grid-template-columns:repeat(5,1fr);border-bottom:1px solid var(--lt)}\n#au-tyl2056 .si{padding:10px 16px;border-right:1px solid var(--lt);background:var(--gb)}\n#au-tyl2056 .si:last-child{border-right:none}\n#au-tyl2056 .sl{font-size:9px;font-weight:700;color:var(--gx);letter-spacing:.1em;text-transform:uppercase;margin-bottom:3px}\n#au-tyl2056 .sv{font-size:12.5px;font-weight:700;color:var(--bk)}\n#au-tyl2056 .tabs{display:flex;border-bottom:2px solid var(--lt);background:var(--wh)}\n#au-tyl2056 .tl{padding:12px 22px;font-size:12px;font-weight:600;cursor:pointer;color:var(--gx);border-bottom:2px solid transparent;margin-bottom:-2px;transition:color .15s,border-color .15s;user-select:none;display:block}\n#au-tyl2056 .tl:hover{color:var(--g2)}\n#au-tyl2056 .pls .pl{display:none;padding:28px 32px 36px}\n#au-tyl2056 #ty-pd:checked  ~ .tabs .tl[for=\"ty-pd\"],\n#au-tyl2056 #ty-tds:checked ~ .tabs .tl[for=\"ty-tds\"],\n#au-tyl2056 #ty-sds:checked ~ .tabs .tl[for=\"ty-sds\"],\n#au-tyl2056 #ty-coa:checked ~ .tabs .tl[for=\"ty-coa\"]{color:var(--g1);border-bottom-color:var(--g1)}\n#au-tyl2056 #ty-pd:checked  ~ .pls #tp-pd,\n#au-tyl2056 #ty-tds:checked ~ .pls #tp-tds,\n#au-tyl2056 #ty-sds:checked ~ .pls #tp-sds,\n#au-tyl2056 #ty-coa:checked ~ .pls #tp-coa{display:block}\n#au-tyl2056 .sh{font-size:10px;font-weight:700;letter-spacing:.12em;text-transform:uppercase;color:var(--wh);background:var(--g1);padding:5px 12px;margin:26px 0 12px;display:inline-block}\n#au-tyl2056 .sh:first-child{margin-top:0}\n#au-tyl2056 p{font-size:13.5px;color:var(--ch);line-height:1.72;margin:0 0 14px}\n#au-tyl2056 .kv{width:100%;border-collapse:collapse;margin-bottom:18px;font-size:13px}\n#au-tyl2056 .kv tr{border-bottom:1px solid var(--lt)}\n#au-tyl2056 .kv tr:last-child{border-bottom:none}\n#au-tyl2056 .kv td{padding:7px 12px 7px 0;vertical-align:top}\n#au-tyl2056 .kv td:first-child{width:34%;font-weight:600;color:var(--gx);padding-right:18px}\n#au-tyl2056 .dt{width:100%;border-collapse:collapse;font-size:12.5px;margin-bottom:18px}\n#au-tyl2056 .dt thead tr{background:var(--g1)}\n#au-tyl2056 .dt thead th{color:var(--wh);padding:8px 12px;text-align:left;font-size:10px;font-weight:700;letter-spacing:.08em;text-transform:uppercase}\n#au-tyl2056 .dt tbody tr:nth-child(even){background:var(--gb)}\n#au-tyl2056 .dt tbody td{padding:7px 12px;border-bottom:1px solid var(--lt);color:var(--ch);vertical-align:top}\n#au-tyl2056 .cards{display:grid;grid-template-columns:repeat(3,1fr);gap:14px;margin-bottom:22px}\n#au-tyl2056 .card{border:1px solid var(--lt);border-top:3px solid var(--g2);padding:16px;border-radius:2px}\n#au-tyl2056 .card-icon{font-size:22px;margin-bottom:8px}\n#au-tyl2056 .card-title{font-size:11px;font-weight:700;color:var(--g1);text-transform:uppercase;letter-spacing:.08em;margin-bottom:7px}\n#au-tyl2056 .card-body{font-size:12.5px;color:var(--ch);line-height:1.6}\n#au-tyl2056 .two-col{display:grid;grid-template-columns:1fr 1fr;gap:26px;margin-bottom:18px}\n#au-tyl2056 .pass{display:inline-block;background:#D1FAE5;color:#065F46;font-size:10px;font-weight:700;padding:2px 9px;border-radius:2px}\n#au-tyl2056 .conform{display:inline-block;background:#DBEAFE;color:var(--bl);font-size:10px;font-weight:700;padding:2px 9px;border-radius:2px}\n#au-tyl2056 .sig{display:grid;grid-template-columns:1fr 1fr;gap:26px;margin-top:26px}\n#au-tyl2056 .sigb{border-top:2px solid var(--g1);padding-top:10px}\n#au-tyl2056 .sigb .sname{font-size:13px;font-weight:700;color:var(--bk)}\n#au-tyl2056 .sigb .srole{font-size:11px;color:var(--gx)}\n#au-tyl2056 .sigb .sdate{font-size:11px;color:var(--gx);margin-top:4px}\n#au-tyl2056 .note{border-left:3px solid var(--g2);background:var(--ga);padding:11px 16px;font-size:12.5px;color:var(--ch);margin-bottom:18px;line-height:1.65}\n#au-tyl2056 .warn{border-left:3px solid var(--or);background:#FFFBEB;padding:11px 16px;font-size:12.5px;color:#78350F;margin-bottom:18px;line-height:1.65}\n#au-tyl2056 .danger{border-left:3px solid var(--rd);background:#FEF2F2;padding:11px 16px;font-size:12.5px;color:#7F1D1D;margin-bottom:18px;line-height:1.65}\n#au-tyl2056 .concl{border-left:4px solid var(--g1);background:var(--ga);padding:14px 20px;font-size:13.5px;color:var(--ch);margin:18px 0;line-height:1.6}\n#au-tyl2056 .disc{margin-top:30px;border:1px solid var(--lt);padding:14px 18px;font-size:11px;color:var(--gx);line-height:1.65;font-style:italic;background:var(--gb)}\n#au-tyl2056 .foot{border-top:1px solid var(--lt);padding:12px 32px;font-size:11px;color:var(--gx);text-align:center;background:var(--gb)}\n@media(max-width:640px){\n  #au-tyl2056 .hdr{flex-direction:column;padding:18px 20px}\n  #au-tyl2056 .strip{grid-template-columns:repeat(3,1fr)}\n  #au-tyl2056 .pls .pl{padding:20px}\n  #au-tyl2056 .two-col,.sig{grid-template-columns:1fr}\n  #au-tyl2056 .cards{grid-template-columns:1fr}\n  #au-tyl2056 .tl{padding:10px 13px;font-size:11px}\n}\n\u003c\/style\u003e\n\n\u003cinput class=\"r\" type=\"radio\" name=\"ty-tabs\" id=\"ty-pd\" checked\u003e\n\u003cinput class=\"r\" type=\"radio\" name=\"ty-tabs\" id=\"ty-tds\"\u003e\n\u003cinput class=\"r\" type=\"radio\" name=\"ty-tabs\" id=\"ty-sds\"\u003e\n\u003cinput class=\"r\" type=\"radio\" name=\"ty-tabs\" id=\"ty-coa\"\u003e\n\n\u003c!-- HEADER --\u003e\n\u003cdiv class=\"hdr\"\u003e\n  \u003cdiv class=\"hdr-l\"\u003e\n    \u003cdiv class=\"cat\"\u003eMacrolide Antibiotic · Research Grade · Streptomyces fradiae\u003c\/div\u003e\n    \u003cdiv class=\"pname\"\u003eTylosin Tartrate\u003c\/div\u003e\n    \u003cdiv class=\"psub\"\u003eC₄₆H₇₇NO₁₇ · C₄H₆O₆  ·  CAS 74610-55-2  ·  MW 1,154.32 g\/mol\u003c\/div\u003e\n    \u003cdiv class=\"badges\"\u003e\n      \u003cspan class=\"badge\"\u003eMacrolide Antibiotic\u003c\/span\u003e\n      \u003cspan class=\"badge\"\u003e50S Ribosomal Inhibitor\u003c\/span\u003e\n      \u003cspan class=\"badge\"\u003ePurity ≥ 95%\u003c\/span\u003e\n      \u003cspan class=\"badge\"\u003eResearch Grade\u003c\/span\u003e\n      \u003cspan class=\"badge\"\u003eBatch Traceable\u003c\/span\u003e\n      \u003cspan class=\"badge\"\u003eCOA Available\u003c\/span\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n  \u003cdiv class=\"hdr-r\"\u003e\n    \u003cdiv class=\"brand\"\u003eAuSaMicS\u003c\/div\u003e\n    \u003cdiv class=\"brand-s\"\u003eLife Science™\u003c\/div\u003e\n  \u003c\/div\u003e\n\u003c\/div\u003e\n\n\u003c!-- STRIP --\u003e\n\u003cdiv class=\"strip\"\u003e\n  \u003cdiv class=\"si\"\u003e\n\u003cdiv class=\"sl\"\u003eCat No.\u003c\/div\u003e\n\u003cdiv class=\"sv\"\u003eASA-2056\u003c\/div\u003e\n\u003c\/div\u003e\n  \u003cdiv class=\"si\"\u003e\n\u003cdiv class=\"sl\"\u003eCAS No.\u003c\/div\u003e\n\u003cdiv class=\"sv\"\u003e74610-55-2\u003c\/div\u003e\n\u003c\/div\u003e\n  \u003cdiv class=\"si\"\u003e\n\u003cdiv class=\"sl\"\u003eMol. Weight\u003c\/div\u003e\n\u003cdiv class=\"sv\"\u003e1,154.32 g\/mol\u003c\/div\u003e\n\u003c\/div\u003e\n  \u003cdiv class=\"si\"\u003e\n\u003cdiv class=\"sl\"\u003ePurity\u003c\/div\u003e\n\u003cdiv class=\"sv\"\u003e≥ 95%\u003c\/div\u003e\n\u003c\/div\u003e\n  \u003cdiv class=\"si\"\u003e\n\u003cdiv class=\"sl\"\u003eStorage\u003c\/div\u003e\n\u003cdiv class=\"sv\"\u003eCool, dry, dark\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\n\u003c!-- TABS --\u003e\n\u003cdiv class=\"tabs\"\u003e\n  \u003clabel class=\"tl\" for=\"ty-pd\"\u003eProduct Description\u003c\/label\u003e\n  \u003clabel class=\"tl\" for=\"ty-tds\"\u003eTechnical Data Sheet\u003c\/label\u003e\n  \u003clabel class=\"tl\" for=\"ty-sds\"\u003eSafety Data Sheet\u003c\/label\u003e\n  \u003clabel class=\"tl\" for=\"ty-coa\"\u003eCertificate of Analysis\u003c\/label\u003e\n\u003c\/div\u003e\n\n\u003cdiv class=\"pls\"\u003e\n\n\u003c!-- TAB 1: PD --\u003e\n\u003cdiv class=\"pl\" id=\"tp-pd\"\u003e\n\u003cdiv class=\"danger\"\u003e⚠  \u003cstrong\u003eFor Research Use Only.\u003c\/strong\u003e Not for human or veterinary therapeutic use. Handle under appropriate biosafety precautions.\u003c\/div\u003e\n\n\u003cdiv class=\"sh\"\u003eOverview\u003c\/div\u003e\n\u003cp\u003eTylosin Tartrate is a water-soluble salt form of Tylosin, a naturally occurring macrolide antibiotic produced by \u003cem\u003eStreptomyces fradiae\u003c\/em\u003e. It exerts its antimicrobial effect by binding to the \u003cstrong\u003e50S ribosomal subunit\u003c\/strong\u003e of susceptible bacteria, thereby inhibiting protein synthesis. Tylosin Tartrate is primarily active against Gram-positive bacteria and select Gram-negative and mycoplasmal organisms.\u003c\/p\u003e\n\u003cp\u003eThe tartrate salt form offers superior aqueous solubility compared to the free base, making it particularly suitable for preparation of liquid culture media, antimicrobial susceptibility testing solutions, and selective agar formulations. AuSaMicS supplies Tylosin Tartrate at research grade (≥ 95% purity) with full batch traceability and Certificate of Analysis.\u003c\/p\u003e\n\n\u003cdiv class=\"sh\"\u003eChemical Identity\u003c\/div\u003e\n\u003ctable class=\"kv\"\u003e\n  \u003ctr\u003e\n\u003ctd\u003eProduct Name\u003c\/td\u003e\n\u003ctd\u003eTylosin Tartrate\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003eChemical Name\u003c\/td\u003e\n\u003ctd\u003eTylosin, (2R,3R)-2,3-dihydroxybutanedioate (salt)\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003eMolecular Formula\u003c\/td\u003e\n\u003ctd\u003eC₄₆H₇₇NO₁₇ · C₄H₆O₆\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003eMolecular Weight\u003c\/td\u003e\n\u003ctd\u003e1,154.32 g\/mol\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003eCAS No.\u003c\/td\u003e\n\u003ctd\u003e74610-55-2\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003eCatalog No.\u003c\/td\u003e\n\u003ctd\u003eASA-2056\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003eAppearance\u003c\/td\u003e\n\u003ctd\u003eWhite to off-white powder\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003eAntibiotic Class\u003c\/td\u003e\n\u003ctd\u003eMacrolide\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003eSource Organism\u003c\/td\u003e\n\u003ctd\u003e\u003cem\u003eStreptomyces fradiae\u003c\/em\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003eMechanism of Action\u003c\/td\u003e\n\u003ctd\u003eInhibits protein synthesis — binds bacterial 50S ribosomal subunit\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003eSpectrum\u003c\/td\u003e\n\u003ctd\u003eGram-positive bacteria; select Gram-negative; Mycoplasma spp.\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003eGrade\u003c\/td\u003e\n\u003ctd\u003eResearch Grade\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003ePurity\u003c\/td\u003e\n\u003ctd\u003e≥ 95%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003cdiv class=\"sh\"\u003eApplications\u003c\/div\u003e\n\u003cdiv class=\"cards\"\u003e\n  \u003cdiv class=\"card\"\u003e\n    \u003cdiv class=\"card-icon\"\u003e🧪\u003c\/div\u003e\n    \u003cdiv class=\"card-title\"\u003eResistance Research\u003c\/div\u003e\n    \u003cdiv class=\"card-body\"\u003eStudies on macrolide resistance mechanisms, efflux pumps, and ribosomal modification in bacterial strains.\u003c\/div\u003e\n  \u003c\/div\u003e\n  \u003cdiv class=\"card\"\u003e\n    \u003cdiv class=\"card-icon\"\u003e🔬\u003c\/div\u003e\n    \u003cdiv class=\"card-title\"\u003eSelective Media\u003c\/div\u003e\n    \u003cdiv class=\"card-body\"\u003eSelective agent in microbiological culture media for isolation of resistant or target organisms from mixed populations.\u003c\/div\u003e\n  \u003c\/div\u003e\n  \u003cdiv class=\"card\"\u003e\n    \u003cdiv class=\"card-icon\"\u003e📋\u003c\/div\u003e\n    \u003cdiv class=\"card-title\"\u003eSusceptibility Testing\u003c\/div\u003e\n    \u003cdiv class=\"card-body\"\u003eAntimicrobial susceptibility testing (AST) — MIC determination, disk diffusion, and broth microdilution assays.\u003c\/div\u003e\n  \u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"note\"\u003eAdditional applications include veterinary and agricultural research studies, gut microbiome modulation research, and as a reference standard in analytical method development.\u003c\/div\u003e\n\n\u003cdiv class=\"sh\"\u003ePackaging\u003c\/div\u003e\n\u003ctable class=\"kv\"\u003e\n  \u003ctr\u003e\n\u003ctd\u003eAvailable Sizes\u003c\/td\u003e\n\u003ctd\u003e1 g  ·  5 g  ·  10 g  ·  Bulk quantities on request\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003eContainer\u003c\/td\u003e\n\u003ctd\u003eAmber glass vial or sealed HDPE container\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003eLabelling\u003c\/td\u003e\n\u003ctd\u003eBatch number, CAS, purity, storage conditions, safety warnings\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003cdiv class=\"sh\"\u003eStorage \u0026amp; Stability\u003c\/div\u003e\n\u003ctable class=\"kv\"\u003e\n  \u003ctr\u003e\n\u003ctd\u003eStorage\u003c\/td\u003e\n\u003ctd\u003eCool, dry place; protected from light; tightly closed\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003eRecommended Temp.\u003c\/td\u003e\n\u003ctd\u003e2–8 °C (refrigerator) for long-term storage; RT acceptable short-term\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003eShelf Life\u003c\/td\u003e\n\u003ctd\u003eSee retest date on label; typically 3 years from manufacture under correct conditions\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003eSolution Stability\u003c\/td\u003e\n\u003ctd\u003ePrepare fresh aqueous solutions; store at 4 °C for up to 2 weeks; freeze at −20 °C for longer storage\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003cdiv class=\"disc\"\u003e\n\u003cstrong\u003eAuSaMicS Pty Ltd\u003c\/strong\u003e (ABN 56 676 640 467) · For research use only. Not for human or veterinary therapeutic use. · 31 Longview CT, Thomastown VIC 3074, Australia · support@ausamics.com · +61 412 520 598 · www.ausamics.com.au\u003c\/div\u003e\n\u003c\/div\u003e\n\n\u003c!-- TAB 2: TDS --\u003e\n\u003cdiv class=\"pl\" id=\"tp-tds\"\u003e\n\u003cdiv class=\"two-col\"\u003e\n  \u003cdiv\u003e\n    \u003cdiv class=\"sh\"\u003eProduct Identification\u003c\/div\u003e\n    \u003ctable class=\"kv\"\u003e\n      \u003ctr\u003e\n\u003ctd\u003eProduct Name\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eTylosin Tartrate\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n      \u003ctr\u003e\n\u003ctd\u003eCat No.\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eASA-2056\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n      \u003ctr\u003e\n\u003ctd\u003eCAS No.\u003c\/td\u003e\n\u003ctd\u003e74610-55-2\u003c\/td\u003e\n\u003c\/tr\u003e\n      \u003ctr\u003e\n\u003ctd\u003eAntibiotic Class\u003c\/td\u003e\n\u003ctd\u003eMacrolide\u003c\/td\u003e\n\u003c\/tr\u003e\n      \u003ctr\u003e\n\u003ctd\u003eGrade\u003c\/td\u003e\n\u003ctd\u003eResearch Grade\u003c\/td\u003e\n\u003c\/tr\u003e\n      \u003ctr\u003e\n\u003ctd\u003ePurity\u003c\/td\u003e\n\u003ctd\u003e≥ 95%\u003c\/td\u003e\n\u003c\/tr\u003e\n      \u003ctr\u003e\n\u003ctd\u003ePack Sizes\u003c\/td\u003e\n\u003ctd\u003e1 g · 5 g · 10 g · Bulk\u003c\/td\u003e\n\u003c\/tr\u003e\n    \u003c\/table\u003e\n  \u003c\/div\u003e\n  \u003cdiv\u003e\n    \u003cdiv class=\"sh\"\u003ePhysical Properties\u003c\/div\u003e\n    \u003ctable class=\"kv\"\u003e\n      \u003ctr\u003e\n\u003ctd\u003eAppearance\u003c\/td\u003e\n\u003ctd\u003eWhite to off-white powder\u003c\/td\u003e\n\u003c\/tr\u003e\n      \u003ctr\u003e\n\u003ctd\u003eMolecular Formula\u003c\/td\u003e\n\u003ctd\u003eC₄₆H₇₇NO₁₇ · C₄H₆O₆\u003c\/td\u003e\n\u003c\/tr\u003e\n      \u003ctr\u003e\n\u003ctd\u003eMolecular Weight\u003c\/td\u003e\n\u003ctd\u003e1,154.32 g\/mol\u003c\/td\u003e\n\u003c\/tr\u003e\n      \u003ctr\u003e\n\u003ctd\u003eSolubility (water)\u003c\/td\u003e\n\u003ctd\u003eSoluble — enhanced vs. free base\u003c\/td\u003e\n\u003c\/tr\u003e\n      \u003ctr\u003e\n\u003ctd\u003eSolubility (MeOH)\u003c\/td\u003e\n\u003ctd\u003eSoluble\u003c\/td\u003e\n\u003c\/tr\u003e\n      \u003ctr\u003e\n\u003ctd\u003eUV Absorption\u003c\/td\u003e\n\u003ctd\u003e~290 nm (characteristic macrolide)\u003c\/td\u003e\n\u003c\/tr\u003e\n      \u003ctr\u003e\n\u003ctd\u003eStorage\u003c\/td\u003e\n\u003ctd\u003e2–8 °C, dark, dry\u003c\/td\u003e\n\u003c\/tr\u003e\n    \u003c\/table\u003e\n  \u003c\/div\u003e\n\u003c\/div\u003e\n\n\u003cdiv class=\"sh\"\u003eMechanism of Action\u003c\/div\u003e\n\u003ctable class=\"kv\"\u003e\n  \u003ctr\u003e\n\u003ctd\u003eTarget\u003c\/td\u003e\n\u003ctd\u003eBacterial 50S ribosomal subunit (23S rRNA)\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003eAction\u003c\/td\u003e\n\u003ctd\u003eInhibits protein synthesis by blocking translocation and peptidyl transfer\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003eSpectrum\u003c\/td\u003e\n\u003ctd\u003ePrimarily Gram-positive bacteria; some Gram-negative; \u003cem\u003eMycoplasma\u003c\/em\u003e, \u003cem\u003eUreaplasma\u003c\/em\u003e spp.\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003eBacteriostatic \/ cidal\u003c\/td\u003e\n\u003ctd\u003ePrimarily bacteriostatic at standard concentrations\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003eResistance Mechanism\u003c\/td\u003e\n\u003ctd\u003eRibosomal methylation (erm genes); efflux pumps (mef genes); enzymatic inactivation\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003cdiv class=\"sh\"\u003ePreparation Guidelines\u003c\/div\u003e\n\u003ctable class=\"kv\"\u003e\n  \u003ctr\u003e\n\u003ctd\u003eStock Solution\u003c\/td\u003e\n\u003ctd\u003eDissolve in sterile water or methanol at 10–50 mg\/mL; vortex until clear; filter through 0.22 µm\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003eWorking Concentration\u003c\/td\u003e\n\u003ctd\u003eTypical MIC range: 0.5–64 µg\/mL depending on organism\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003eMedia Supplementation\u003c\/td\u003e\n\u003ctd\u003eAdd aseptically after autoclaving at 45–50 °C; avoid prolonged heat exposure\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003epH Stability\u003c\/td\u003e\n\u003ctd\u003eStable pH 4–8; avoid strongly acidic or alkaline conditions\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003eIncompatibilities\u003c\/td\u003e\n\u003ctd\u003eStrong oxidising agents; avoid prolonged exposure to high temperatures\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003cdiv class=\"sh\"\u003eQuality Control Specifications\u003c\/div\u003e\n\u003ctable class=\"dt\"\u003e\n  \u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eParameter\u003c\/th\u003e\n\u003cth\u003eSpecification\u003c\/th\u003e\n\u003cth\u003eMethod\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n  \u003ctbody\u003e\n    \u003ctr\u003e\n\u003ctd\u003eAppearance\u003c\/td\u003e\n\u003ctd\u003eWhite to off-white powder; no visible impurities\u003c\/td\u003e\n\u003ctd\u003eVisual inspection\u003c\/td\u003e\n\u003c\/tr\u003e\n    \u003ctr\u003e\n\u003ctd\u003ePurity (HPLC)\u003c\/td\u003e\n\u003ctd\u003e≥ 95%\u003c\/td\u003e\n\u003ctd\u003eHPLC (reversed phase, UV 290 nm)\u003c\/td\u003e\n\u003c\/tr\u003e\n    \u003ctr\u003e\n\u003ctd\u003eIdentity\u003c\/td\u003e\n\u003ctd\u003eConfirmed by UV-Vis and MS\u003c\/td\u003e\n\u003ctd\u003eUV-Vis \/ LC-MS\u003c\/td\u003e\n\u003c\/tr\u003e\n    \u003ctr\u003e\n\u003ctd\u003eLoss on Drying\u003c\/td\u003e\n\u003ctd\u003e≤ 5.0% w\/w\u003c\/td\u003e\n\u003ctd\u003e105 °C \/ 2 h (gravimetric)\u003c\/td\u003e\n\u003c\/tr\u003e\n    \u003ctr\u003e\n\u003ctd\u003eSolubility\u003c\/td\u003e\n\u003ctd\u003eClear solution at 10 mg\/mL in water\u003c\/td\u003e\n\u003ctd\u003eSolution test\u003c\/td\u003e\n\u003c\/tr\u003e\n    \u003ctr\u003e\n\u003ctd\u003eBiological Activity\u003c\/td\u003e\n\u003ctd\u003eInhibition zone ≥ 18 mm vs. \u003cem\u003eS. aureus\u003c\/em\u003e ATCC 25923 (disk diffusion)\u003c\/td\u003e\n\u003ctd\u003eKirby-Bauer disk diffusion\u003c\/td\u003e\n\u003c\/tr\u003e\n    \u003ctr\u003e\n\u003ctd\u003eHeavy Metals\u003c\/td\u003e\n\u003ctd\u003e≤ 20 ppm (Pb equiv.)\u003c\/td\u003e\n\u003ctd\u003eICP-MS\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cdiv class=\"sh\"\u003eTechnical References\u003c\/div\u003e\n\u003ctable class=\"kv\"\u003e\n  \u003ctr\u003e\n\u003ctd\u003eAntibiotic Class\u003c\/td\u003e\n\u003ctd\u003eMacrolide — 16-membered lactone ring; produced by \u003cem\u003eStreptomyces fradiae\u003c\/em\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003eClinical Relevance\u003c\/td\u003e\n\u003ctd\u003eVeterinary macrolide antibiotic; model compound for macrolide resistance studies\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003eCLSI \/ EUCAST\u003c\/td\u003e\n\u003ctd\u003eReference breakpoints available for susceptibility testing (veterinary organisms)\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003eRelated Compounds\u003c\/td\u003e\n\u003ctd\u003eTylosin A (major), Tylosin B (Desmycosin), Tylosin C, Tylosin D\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003cdiv class=\"disc\"\u003e\n\u003cstrong\u003eAuSaMicS Pty Ltd\u003c\/strong\u003e (ABN 56 676 640 467) · 31 Longview CT, Thomastown VIC 3074 · support@ausamics.com · www.ausamics.com.au\u003c\/div\u003e\n\u003c\/div\u003e\n\n\u003c!-- TAB 3: SDS --\u003e\n\u003cdiv class=\"pl\" id=\"tp-sds\"\u003e\n\u003cdiv class=\"warn\"\u003e\n\u003cstrong\u003eSafety Data Sheet — GHS Format (Australian WHS Regulations 2017)\u003c\/strong\u003e\u003cbr\u003eIssue Date: March 2026 · Rev: 1.0\u003c\/div\u003e\n\n\u003cdiv class=\"sh\"\u003eSection 1 — Identification\u003c\/div\u003e\n\u003ctable class=\"kv\"\u003e\n  \u003ctr\u003e\n\u003ctd\u003eProduct Name\u003c\/td\u003e\n\u003ctd\u003eTylosin Tartrate — ASA-2056\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003eCAS No.\u003c\/td\u003e\n\u003ctd\u003e74610-55-2\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003eIntended Use\u003c\/td\u003e\n\u003ctd\u003eResearch reagent — antimicrobial agent for laboratory use only\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003eSupplier\u003c\/td\u003e\n\u003ctd\u003eAuSaMicS Pty Ltd, 31 Longview CT, Thomastown VIC 3074, Australia\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003ePhone \/ Emergency\u003c\/td\u003e\n\u003ctd\u003e+61 412 520 598 · Poisons Centre: 13 11 26 (24h)\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003eEmail \/ Web\u003c\/td\u003e\n\u003ctd\u003esupport@ausamics.com · www.ausamics.com.au\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003cdiv class=\"sh\"\u003eSection 2 — Hazard Identification\u003c\/div\u003e\n\u003ctable class=\"kv\"\u003e\n  \u003ctr\u003e\n\u003ctd\u003eGHS Classification\u003c\/td\u003e\n\u003ctd\u003eH317: May cause allergic skin reaction (sensitiser). H334: May cause allergy or asthma symptoms or breathing difficulties if inhaled.\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003eSignal Word\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eWarning\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003eHazard Statements\u003c\/td\u003e\n\u003ctd\u003eH317 · H334 — sensitisation risk for beta-lactam\/macrolide-sensitive individuals\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003ePrecautionary\u003c\/td\u003e\n\u003ctd\u003eP260 · P272 · P280 · P284 · P302+P352 · P342+P311 · P501\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003eAntibiotic Hazard\u003c\/td\u003e\n\u003ctd\u003eContains active antibiotic — avoid unnecessary environmental release; do not discharge to drains without inactivation\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003eSensitisation\u003c\/td\u003e\n\u003ctd\u003eMacrolide antibiotics are known sensitisers — personnel with known macrolide hypersensitivity should avoid handling\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003cdiv class=\"sh\"\u003eSection 3 — Composition\u003c\/div\u003e\n\u003ctable class=\"dt\"\u003e\n  \u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eComponent\u003c\/th\u003e\n\u003cth\u003eCAS No.\u003c\/th\u003e\n\u003cth\u003eProportion\u003c\/th\u003e\n\u003cth\u003eGHS Classification\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n  \u003ctbody\u003e\n    \u003ctr\u003e\n\u003ctd\u003eTylosin Tartrate\u003c\/td\u003e\n\u003ctd\u003e74610-55-2\u003c\/td\u003e\n\u003ctd\u003e≥ 95%\u003c\/td\u003e\n\u003ctd\u003eH317 · H334\u003c\/td\u003e\n\u003c\/tr\u003e\n    \u003ctr\u003e\n\u003ctd\u003eRelated macrolide impurities\u003c\/td\u003e\n\u003ctd\u003e—\u003c\/td\u003e\n\u003ctd\u003e≤ 5%\u003c\/td\u003e\n\u003ctd\u003eNot classified at supplied levels\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cdiv class=\"sh\"\u003eSections 4–8 — First Aid, Fire, Spill, Handling, PPE\u003c\/div\u003e\n\u003ctable class=\"kv\"\u003e\n  \u003ctr\u003e\n\u003ctd\u003eInhalation\u003c\/td\u003e\n\u003ctd\u003eRemove to fresh air. If allergic response or difficulty breathing develops, seek immediate medical attention. Note: macrolide sensitiser — H334.\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003eSkin Contact\u003c\/td\u003e\n\u003ctd\u003eWash with soap and water ≥ 15 min. H317 — may cause allergic reaction in sensitised individuals. Seek medical advice if reaction occurs.\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003eEye Contact\u003c\/td\u003e\n\u003ctd\u003eRinse with copious water ≥ 15 min. Seek medical attention if irritation persists.\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003eIngestion\u003c\/td\u003e\n\u003ctd\u003eDo not induce vomiting. Rinse mouth. Seek medical advice. Active antibiotic — inform physician of substance.\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003eFire\u003c\/td\u003e\n\u003ctd\u003eNot flammable. CO, CO₂, NOₓ on combustion. Use CO₂ or dry chemical extinguisher.\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003eSpill\u003c\/td\u003e\n\u003ctd\u003eCollect carefully; avoid dust. Decontaminate area with 1% NaOH or bleach solution to inactivate antibiotic. Dispose per Section 13.\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003eRespiratory PPE\u003c\/td\u003e\n\u003ctd\u003eFFP2\/P2 respirator when handling powder — macrolide sensitiser risk\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003eHand Protection\u003c\/td\u003e\n\u003ctd\u003eNitrile gloves — change immediately if contaminated\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003eEye \/ Face\u003c\/td\u003e\n\u003ctd\u003eSafety glasses; goggles if powder generation risk\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003eBody Protection\u003c\/td\u003e\n\u003ctd\u003eLab coat; closed footwear\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003eEngineering Controls\u003c\/td\u003e\n\u003ctd\u003eHandle in fume hood or with local exhaust ventilation; avoid open-bench powder weighing\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003cdiv class=\"sh\"\u003eSections 9–16 — Properties, Stability, Toxicology, Disposal, Regulatory\u003c\/div\u003e\n\u003ctable class=\"kv\"\u003e\n  \u003ctr\u003e\n\u003ctd\u003ePhysical State\u003c\/td\u003e\n\u003ctd\u003eSolid (powder); white to off-white\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003eSolubility\u003c\/td\u003e\n\u003ctd\u003eSoluble in water and methanol\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003eStability\u003c\/td\u003e\n\u003ctd\u003eStable at 2–8 °C, dark, dry. Degrades in strongly acidic\/alkaline conditions.\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003eSkin Sensitisation\u003c\/td\u003e\n\u003ctd\u003eH317 — macrolide class sensitiser\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003eRespiratory Sensitisation\u003c\/td\u003e\n\u003ctd\u003eH334 — may cause asthma\/allergy symptoms on inhalation\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003eAntibiotic Resistance Risk\u003c\/td\u003e\n\u003ctd\u003eContains active macrolide antibiotic — inactivate before environmental disposal to prevent resistance selection\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003eAquatic Toxicity\u003c\/td\u003e\n\u003ctd\u003eAntibiotics are potentially harmful to aquatic microbial communities — prevent discharge to waterways\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003eWaste Disposal\u003c\/td\u003e\n\u003ctd\u003eInactivate with 1% NaOH (pH \u0026gt;10, 30 min) or autoclave 121 °C \/ 30 min before disposal. Dispose via licensed chemical waste contractor. Do NOT discharge active antibiotic to drain.\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003eTransport\u003c\/td\u003e\n\u003ctd\u003eNot classified as dangerous goods (ADG\/IATA\/IMDG) in standard laboratory quantities\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003eAICS (Australia)\u003c\/td\u003e\n\u003ctd\u003eListed on Australian Inventory of Chemical Substances\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003eSUSMP Schedule\u003c\/td\u003e\n\u003ctd\u003eSchedule 4 (Prescription Only Medicine) for therapeutic use — this supply is for research use only\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003eWHS Regulations\u003c\/td\u003e\n\u003ctd\u003eH317\/H334 — hazardous chemical under WHS Regulations 2017; risk assessment required\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003ctr\u003e\n\u003ctd\u003eSDS Prepared By\u003c\/td\u003e\n\u003ctd\u003eAuSaMicS Pty Ltd — Technical \u0026amp; Quality Department · March 2026 · Rev 1.0\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\n\u003cdiv class=\"disc\"\u003e\n\u003cstrong\u003eAuSaMicS Pty Ltd\u003c\/strong\u003e (ABN 56 676 640 467) · 31 Longview CT, Thomastown VIC 3074, Australia · support@ausamics.com · +61 412 520 598 · www.ausamics.com.au\u003cbr\u003eFor research use only. Not for human or veterinary therapeutic use.\u003c\/div\u003e\n\u003c\/div\u003e\n\n\u003c!-- TAB 4: COA --\u003e\n\u003cdiv class=\"pl\" id=\"tp-coa\"\u003e\n\u003cdiv class=\"two-col\"\u003e\n  \u003cdiv\u003e\n    \u003cdiv class=\"sh\"\u003eProduct Details\u003c\/div\u003e\n    \u003ctable class=\"kv\"\u003e\n      \u003ctr\u003e\n\u003ctd\u003eProduct Name\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eTylosin Tartrate\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n      \u003ctr\u003e\n\u003ctd\u003eCatalog No.\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eASA-2056\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n      \u003ctr\u003e\n\u003ctd\u003eCAS No.\u003c\/td\u003e\n\u003ctd\u003e74610-55-2\u003c\/td\u003e\n\u003c\/tr\u003e\n      \u003ctr\u003e\n\u003ctd\u003eLot No.\u003c\/td\u003e\n\u003ctd\u003eTYL260301\u003c\/td\u003e\n\u003c\/tr\u003e\n      \u003ctr\u003e\n\u003ctd\u003eMfg. Date\u003c\/td\u003e\n\u003ctd\u003eMarch 2026\u003c\/td\u003e\n\u003c\/tr\u003e\n      \u003ctr\u003e\n\u003ctd\u003eRetest Date\u003c\/td\u003e\n\u003ctd\u003eMarch 2029\u003c\/td\u003e\n\u003c\/tr\u003e\n      \u003ctr\u003e\n\u003ctd\u003eGrade\u003c\/td\u003e\n\u003ctd\u003eResearch Grade\u003c\/td\u003e\n\u003c\/tr\u003e\n    \u003c\/table\u003e\n  \u003c\/div\u003e\n  \u003cdiv\u003e\n    \u003cdiv class=\"sh\"\u003eDocument Information\u003c\/div\u003e\n    \u003ctable class=\"kv\"\u003e\n      \u003ctr\u003e\n\u003ctd\u003eCOA No.\u003c\/td\u003e\n\u003ctd\u003eCOA-ASA-2056-L001\u003c\/td\u003e\n\u003c\/tr\u003e\n      \u003ctr\u003e\n\u003ctd\u003eIssue Date\u003c\/td\u003e\n\u003ctd\u003eMarch 2026\u003c\/td\u003e\n\u003c\/tr\u003e\n      \u003ctr\u003e\n\u003ctd\u003eIssued By\u003c\/td\u003e\n\u003ctd\u003eAuSaMicS Quality Control\u003c\/td\u003e\n\u003c\/tr\u003e\n      \u003ctr\u003e\n\u003ctd\u003eTest Ref.\u003c\/td\u003e\n\u003ctd\u003eIn-house \/ USP \/ CLSI\u003c\/td\u003e\n\u003c\/tr\u003e\n    \u003c\/table\u003e\n  \u003c\/div\u003e\n\u003c\/div\u003e\n\n\u003cdiv class=\"sh\"\u003eTest Results \u0026amp; Analytical Data\u003c\/div\u003e\n\u003ctable class=\"dt\"\u003e\n  \u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eTest Parameter\u003c\/th\u003e\n\u003cth\u003eSpecification\u003c\/th\u003e\n\u003cth\u003eMethod\u003c\/th\u003e\n\u003cth\u003eResult\u003c\/th\u003e\n\u003cth style=\"text-align:center\"\u003eStatus\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n  \u003ctbody\u003e\n    \u003ctr\u003e\n\u003ctd\u003eAppearance\u003c\/td\u003e\n\u003ctd\u003eWhite to off-white powder; no visible impurities\u003c\/td\u003e\n\u003ctd\u003eVisual inspection\u003c\/td\u003e\n\u003ctd\u003eConforms\u003c\/td\u003e\n\u003ctd style=\"text-align:center\"\u003e\u003cspan class=\"pass\"\u003ePASS\u003c\/span\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n    \u003ctr\u003e\n\u003ctd\u003eIdentity (UV-Vis)\u003c\/td\u003e\n\u003ctd\u003eAbsorption maximum ~290 nm (macrolide characteristic)\u003c\/td\u003e\n\u003ctd\u003eUV-Vis spectrophotometry\u003c\/td\u003e\n\u003ctd\u003e289 nm\u003c\/td\u003e\n\u003ctd style=\"text-align:center\"\u003e\u003cspan class=\"pass\"\u003ePASS\u003c\/span\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n    \u003ctr\u003e\n\u003ctd\u003ePurity (HPLC)\u003c\/td\u003e\n\u003ctd\u003e≥ 95%\u003c\/td\u003e\n\u003ctd\u003eHPLC reversed phase, UV 290 nm\u003c\/td\u003e\n\u003ctd\u003e97.2%\u003c\/td\u003e\n\u003ctd style=\"text-align:center\"\u003e\u003cspan class=\"pass\"\u003ePASS\u003c\/span\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n    \u003ctr\u003e\n\u003ctd\u003eLoss on Drying\u003c\/td\u003e\n\u003ctd\u003e≤ 5.0% w\/w\u003c\/td\u003e\n\u003ctd\u003e105 °C \/ 2 h (gravimetric)\u003c\/td\u003e\n\u003ctd\u003e2.8%\u003c\/td\u003e\n\u003ctd style=\"text-align:center\"\u003e\u003cspan class=\"pass\"\u003ePASS\u003c\/span\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n    \u003ctr\u003e\n\u003ctd\u003eSolubility (10 mg\/mL, water)\u003c\/td\u003e\n\u003ctd\u003eClear solution; complete dissolution\u003c\/td\u003e\n\u003ctd\u003eSolution test\u003c\/td\u003e\n\u003ctd\u003eClear\u003c\/td\u003e\n\u003ctd style=\"text-align:center\"\u003e\u003cspan class=\"pass\"\u003ePASS\u003c\/span\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n    \u003ctr\u003e\n\u003ctd\u003eBiological Activity (disk diffusion)\u003c\/td\u003e\n\u003ctd\u003eInhibition zone ≥ 18 mm vs. \u003cem\u003eS. aureus\u003c\/em\u003e ATCC 25923\u003c\/td\u003e\n\u003ctd\u003eKirby-Bauer disk diffusion\u003c\/td\u003e\n\u003ctd\u003e22 mm\u003c\/td\u003e\n\u003ctd style=\"text-align:center\"\u003e\u003cspan class=\"pass\"\u003ePASS\u003c\/span\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n    \u003ctr\u003e\n\u003ctd\u003eHeavy Metals (Pb equiv.)\u003c\/td\u003e\n\u003ctd\u003e≤ 20 ppm\u003c\/td\u003e\n\u003ctd\u003eICP-MS\u003c\/td\u003e\n\u003ctd\u003e\u0026lt; 5 ppm\u003c\/td\u003e\n\u003ctd style=\"text-align:center\"\u003e\u003cspan class=\"pass\"\u003ePASS\u003c\/span\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n    \u003ctr\u003e\n\u003ctd\u003eCAS Identity Verification\u003c\/td\u003e\n\u003ctd\u003eCAS 74610-55-2 confirmed\u003c\/td\u003e\n\u003ctd\u003eLC-MS comparison vs. reference\u003c\/td\u003e\n\u003ctd\u003eConfirmed\u003c\/td\u003e\n\u003ctd style=\"text-align:center\"\u003e\u003cspan class=\"conform\"\u003eCONFORM\u003c\/span\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n  \u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cdiv class=\"concl\"\u003e\n  \u003cstrong style=\"color:#1A4731\"\u003eConclusion:\u003c\/strong\u003e Lot TYL260301 fully meets all release specifications for Tylosin Tartrate (CAS 74610-55-2). Purity 97.2% (≥ 95% spec.), biological activity confirmed. This lot is \u003cstrong style=\"color:#1A4731\"\u003eRELEASED for research use.\u003c\/strong\u003e\n\u003c\/div\u003e\n\n\u003cdiv class=\"sig\"\u003e\n  \u003cdiv class=\"sigb\"\u003e\n    \u003cdiv class=\"sname\"\u003eQuality Control Analyst\u003c\/div\u003e\n    \u003cdiv class=\"srole\"\u003eAuSaMicS Quality Control Department\u003c\/div\u003e\n    \u003cdiv class=\"sdate\"\u003eDate: March 2026  |  Signature: _______________\u003c\/div\u003e\n  \u003c\/div\u003e\n  \u003cdiv class=\"sigb\"\u003e\n    \u003cdiv class=\"sname\"\u003eQuality Manager\u003c\/div\u003e\n    \u003cdiv class=\"srole\"\u003eAuSaMicS Pty Ltd\u003c\/div\u003e\n    \u003cdiv class=\"sdate\"\u003eDate: March 2026  |  Signature: _______________\u003c\/div\u003e\n  \u003c\/div\u003e\n\u003c\/div\u003e\n\n\u003cdiv class=\"disc\"\u003e\n\u003cstrong\u003eAuSaMicS Pty Ltd\u003c\/strong\u003e (ABN 56 676 640 467) warrants this product meets specifications at time of manufacture. For research use only. Not for human or veterinary therapeutic use. Results specific to Lot TYL260301 only. · 31 Longview CT, Thomastown VIC 3074, Australia · support@ausamics.com · +61 412 520 598 · www.ausamics.com.au\u003c\/div\u003e\n\u003c\/div\u003e\n\n\u003c\/div\u003e\n\u003c!-- \/.pls --\u003e\n\u003cdiv class=\"foot\"\u003eAuSaMicS Pty Ltd  ·  ABN 56 676 640 467  ·  31 Longview CT, Thomastown VIC 3074, Australia  ·  support@ausamics.com  ·  +61 412 520 598  ·  www.ausamics.com.au\u003c\/div\u003e\n\u003c\/div\u003e","brand":"Ausamics Life Science","offers":[{"title":"500 mg","offer_id":48309317501183,"sku":"ASA-2056-500MG","price":49.0,"currency_code":"AUD","in_stock":true},{"title":"1 g","offer_id":48309317533951,"sku":"ASA-2056-1G","price":79.0,"currency_code":"AUD","in_stock":true}],"url":"https:\/\/ausamics.com.au\/products\/tylosin-tartrate-cas-74610-55-2","provider":"AuSaMicS","version":"1.0","type":"link"}